Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Tina-quant Hemoglobin A1cDx Gen.3

K-Number: K193053 · 2020-03-26

Decision Date2020-03-26
Product CodePDJ
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

Tina-quant Hemoglobin A1cDx Gen.3 is a medical device manufactured by Roche Diagnostics Operations (Rdo). It received FDA 510(k) clearance on 2020-03-26 under approval number K193053. The device is classified under product code PDJ. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Tina-quant Hemoglobin A1cDx Gen.3?

Tina-quant Hemoglobin A1cDx Gen.3 is a medical device that received FDA 510(k) clearance on 2020-03-26. It is manufactured by Roche Diagnostics Operations (Rdo). The 510(k) number is K193053.

When was Tina-quant Hemoglobin A1cDx Gen.3 approved by the FDA?

Tina-quant Hemoglobin A1cDx Gen.3 received FDA 510(k) clearance on 2020-03-26, under approval number K193053.

What company makes Tina-quant Hemoglobin A1cDx Gen.3?

Tina-quant Hemoglobin A1cDx Gen.3 is manufactured by Roche Diagnostics Operations (Rdo).

What is the FDA product code for Tina-quant Hemoglobin A1cDx Gen.3?

The FDA product code for Tina-quant Hemoglobin A1cDx Gen.3 is PDJ.

Other Devices by Roche Diagnostics Operations (Rdo)

View all 10 devices →

Related Devices (Code: PDJ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.